Pharmaceutical
Humacyte's VA Contract: A Milestone for Symvess Surgical Implants
Humacyte secures a vital contract with the VA for Symvess, boosting access to 170 hospitals and highlighting its potential in vascular proce…
Tyler Brooks • May 20, 2026
Pharmaceutical
Eli Lilly's Strategic Acquisition of Engage Bio: A Game Changer in Gene Therapy
Eli Lilly's acquisition of Engage Bio for up to $202 million positions it as a key player in non-viral gene delivery.
James McAllister • May 20, 2026